Your browser doesn't support javascript.
loading
An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.
Porter, Chad K; Riddle, Mark S; Alcala, Ashley N; Sack, David A; Harro, Clayton; Chakraborty, Subhra; Gutierrez, Ramiro L; Savarino, Stephen J; Darsley, Michael; McKenzie, Robin; DeNearing, Barbara; Steinsland, Hans; Tribble, David R; Bourgeois, A Louis.
Afiliação
  • Porter CK; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America.
  • Riddle MS; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America.
  • Alcala AN; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America.
  • Sack DA; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America.
  • Harro C; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America.
  • Chakraborty S; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America.
  • Gutierrez RL; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America.
  • Savarino SJ; Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, Silver Spring, MD, United States of America.
  • Darsley M; MD Biologic, LTD, Cambridge, United Kingdom.
  • McKenzie R; School of Medicine, Johns Hopkins University, Baltimore, MD, United States of America.
  • DeNearing B; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America.
  • Steinsland H; Centre for Intervention Science in Maternal and Child Health (CISMAC), Centre for International Health, and Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Tribble DR; Infectious Disease Clinical Research Program, Bethesda, MD, United States of America.
  • Bourgeois AL; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States of America.
PLoS One ; 11(3): e0149358, 2016.
Article em En | MEDLINE | ID: mdl-26938983
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Escherichia coli / Diarreia / Infecções por Escherichia coli / Escherichia coli Enterotoxigênica Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Escherichia coli / Diarreia / Infecções por Escherichia coli / Escherichia coli Enterotoxigênica Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article